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Abstract
Polymyxin B (PMB), a member of polypeptide antibiotics, is widely used for the treatment of infection in animals such as cattle,
sheep, pigs, and chickens. However, it is toxic on the kidneys and nervous system, and polymyxin resistance is increasingly
reported, which leaves a serious threat to human health. Therefore, it is essential to establish rapid methods for detecting PMB
with high sensitivity and specificity. In this study, an anti-PMB polyclonal antibody (pAb) was obtained by immunizing New
Zealand white rabbits with PMB conjugated with glycosylated bovine serum albumin (GBSA). Indirect competitive enzyme-
linked immunosorbent assay (ic-ELISA) and indirect competitive chemiluminescent enzyme immunoassay (ic-CLEIA) were
developed. Under the optimal conditions, inhibitory concentrations (IC50) of PMB were 257.1 ng/mL (ic-ELISA) and 250.8 ng/
mL (ic-CLEIA); the limits of detection (LOD) were 17.4 ng/mL (ic-ELISA) and 14.5 ng/mL (ic-CLEIA), respectively. Cross-
reactivity of the pAb toward polymyxin E (PME) was 257.1%, and no response was found with other antibiotics. The recovery
rates in spiked meat samples were 77.4~106.1% (ic-ELISA) and 84.1~107.1% (ic-CLEIA), respectively.
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Introduction
Polymyxins (PM) are pentacationic polypeptides with a com-
mon structure: a cyclic heptapeptide, a linear tripeptide por-
tion, and a fatty acyl (FA) tail which is linked to the N-
terminus of the tripeptide part (Storm et al. 1977). They have
five different agents, which are described and named as poly-
myxins A–E (Kadar et al. 2013). They differ from each other
in their amino acid sequences and FA chains. Among these
molecules, only PMB and PME are available for clinical use
(Cai et al. 2015). They are isolated from cultures of various
strains of Bacillus polymyxa and related species (Liu et al.
2017; Pendela and Adams 2004). PMB has been used for
the treatment of infections caused by gram-negative bacteria,
especially the Pseudomonas aeruginosa and Escherichia coli
(Gales et al. 2001; Orwa et al. 2000). It is the drug of first
choice in the treatment of infections of the urinary tract, eye,
meninges, and bloodstream. Many countries have promulgat-
ed standards for residue limits of PME. The EU and China
both set up PME residue limits of 150 μg/kg in the animal
muscle, fat, and liver and 200 μg/kg in the kidney. However,
there is no maximum residue limit for PMB in animal-derived
foods and animal feed internationally. PMB has been known
to show antiendotoxin activities, and it is reported to bind to
endotoxin in vitro to suppress many of its activities (Guo et al.
2007; Ronco and Klein 2014). Owing to the emergence of
multidrug-resistant (MDR) gram-negative antibiotics and the
reduction of newly developed antibiotics, PMB has been in-
creasingly used as a last-resort drug in the treatment of MDR
gram-negative bacterial infections (Bergen et al. 2012a;
Velkov et al. 2013).
With the increasing use of PM in humans and animals,
bacterial resistance has been on the increase (Li et al. 2018;
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Olaitan et al. 2014). In 2010, the EuropeanMedicines Agency
warned in their report (Bergen et al. 2012b) about the increas-
ing resistance to PME, especially in Southern European coun-
tries where PME has been frequently used in agriculture. In
the husbandry industry, PMB is used as a feed additive to
promote animal growth. Excessive use of PMB gives rise to
a large amount of residues in animal tissues, which may trans-
fer to humans and put humans at risk for the acquisition of
antibiotic-resistant pathogens (Sitzlar et al. 2012). Therefore,
there is a huge need for quantification of PMB in veterinary
practices and food safety inspection.
There are many different methods used for the determina-
tion of polymyxin: chromatography methods (LC-MS/MS)
have been widely used and recognized as standard laboratory
methods for PMB quantification and subtype identification
with high sensitivity and accuracy. PMB1, PMB2, PMB3, and
isoleucine-PMB1were separated and quantified using stepwise
gradient elution of water containing 0.1% of formic acid and
0.1% of trichloroacetic acid (mobile phase A) and 90% aceto-
nitrile with 0.1% formic acid (mobile phase B) (Hee et al.
2017). These PMBs were completely resolved in the analytical
run time of 6.5 min. Immunoassay is another approach to sen-
sitive, rapid, and cost-effective detection of antibiotics, espe-
cially for field screening of large samples. A highly sensitive
ELISA was developed for the quantification of PMB sulfate
with the detection limit of 32 pg/mL (Saita et al. 1999).
However, this assay was aimed only for the detection of
PMB sulfate in human serum samples. Consequently, it is nec-
essary that a sensitive, rapid, and reliable method should be
developed for the determination of PMB residues in animal-
derived foods.
The present study aimed at developing the most commonly
used quantitative immunoassays, namely, ELISA and CLEIA,
for PMB residue analysis in animal-derived edible tissues.
Materials and Methods
Synthesis of Polymyxin B Conjugates
The glycosylated bovine serum albumin (GBSA) was syn-
thesized via the carbodiimide (EDAC) method (He et al.
2015). PMB (purity 98%, China Food and Drug
Verification Research Institute, Beijing, China) was con-
jugated with GBSA to obtain an immunogen. For the syn-
thesis of GBSA, 10.09 mg of bovine serum albumin
(BSA), 3.30 mg of EDAC, and 10 μL D-gluconic acid
(Sigma, St. Louis, MO, USA) were dissolved in 500 μL
PBS, and the reaction was carried out for 16 h at 17 °C.
Then, the mixture was dialyzed against PBS (0.01 mol/L,
pH 7.4) at 4 °C. The artificial antigens were synthesized
via the sodium periodate oxidation method (Burkin and
Galvidis 2010) (Fig. 1). For the synthesis of the immuniz-
ing antigen, 0.5 mL of 0.1 M NaIO4 was added dropwise
to 10 mg GBSA, which was dissolved in 3.5 mL PBS,
and the mixed solution was stirred for 2 h at room tem-
perature. Then, the mixture was reacted with 0.5 mL of
1 M glycol at RT with continuous stirring for 10 min.
When the reaction ended, the solution obtained was added
to 4 mL of PMB PBS solution and reacted for 2 h. The
pH value of the reaction mixture was adjusted between
9.0 and 9.5 with 5% K2CO3 solution. After this reaction,
10 mg NaBH4 was added into the mixture and reacted for
16 h. Finally, the obtained conjugate (PMB-GBSA) was
dialyzed against four changes of PBS (0.01 M, pH 7.4)
for 3 days.
UV spectra (Specord 50UV-VIS spectrophotometer,
Analytik Jena AG, Germany) of PMB, GBSA, and
PMB-GBSA were tested at a wavelength ranging from
190 to 400 nm. The conjugations were confirmed again
by SDS-PAGE.
Similarly, the coating antigen synthesis PMB-Gelatin
(PMB-Gel) was prepared as described above.
Generation of Polyclonal Antibodies
A half milliliter of saline-containing 500 μg of PMB-
GBSA was emulsified with 500 μL of Freund’s complete
adjuvant and administered intradermally to female New
Zealand white rabbits at sites along both sides of the
spine. After the initial immunization, booster injections
were given four times at biweekly intervals, using
300 μg of PMB-GBSA in 500 μL of Freund’s incomplete
adjuvant (FIA, Sigma, St. Louis, MO, USA) per rabbit per
Fig. 1 Synthetic route for the
immunogen. (A) Synthesis of
GBSA by EDAC; (B) NaIO4
oxidizes the hydroxyl of GBSA;
(C) carbonyl coupled to PMB;
(D) NaBH4 reduces double-
bonded carbonic acid of
conjugation
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booster dose. Post-immunization blood was collected
from the marginal ear vein. Blood was clot for 30 min
and centrifuged at 5000g for 5 min, and the serum was
collected. Serum aliquots were kept at 4 °C for immediate
use and at − 20 °C for long-term storage. It was used as
anti-PMB antiserum for ELISA and CLEIA.
Indirect Competitive ELISA
The optimal dilutions of the antibody and the coating
antigen were determined by checkerboard titration at an
absorption value of 1.0. According to conventional proto-
cols (Cui et al. 2016), the ic-ELISA was carried out as
follows: 96-well ELISA plates (Costar Inc., Cambridge,
MA, USA) were coated with PMB-Gel (100 μL per well)
in 0.1 M sodium carbonate buffer (CBS, pH 9.6) at 4 °C
overnight. The plates were washed three times with PBST
(0.5% Tween-20 in PBS) and blocked with 2% BSA in
PBS (200 μL per well) at 37 °C for 2 h. The same wash-
ing step was implemented. A series of PMB standards and
samples dissolved in PBS were mixed with an equal vol-
ume of diluted serum in PBS. One hundred microliters per
well of the mixture was added to the plates at 37 °C for
40 min. After washing three times, the plates were incu-
bated with goat anti-rabbit HRP (100 μL per well, diluted
1:8000) dissolved in PBS containing 1% BSA at 37 °C
for 40 min. The plates were washed again. Subsequently,
100 μL per well of 3,3′,5,5′-tetramethylbenzidine (TMB,
Sigma, St. Louis, MO, USA) substrate solution was added
to plates, which were then incubated at 37 °C for 10 min.
The reaction was terminated by the addition of 2 M
H2SO4 (50 μL per well). The absorbance values were
measured at 450 nm.
The competition curve was established by plotting the
B/B0 values against the PMB concentrations of 5, 10, 25,
50, 100, 250, 500, 1000, and 2000 ng/mL, where B and
B0 represented the absorbance values of the well contain-
ing the competitor and the zero competitor concentrations,
respectively, relative to the control OD450. The concentra-
tions of PMB in the samples were quantified using the
calibration curve.
Cross-reactivity Assay
Structural analogs and commonly used antibiotics such as
PME, kanamycin, gentamicin, enrofloxacin, sulfadimethox-
ine, and chloramphenicol (Solarbio Science & Technology
Co., Ltd., Beijing, China) were studied for cross-reactivity to
determine the specificity of the antibodies. Cross-reactivity
(CR %) was quantitated as follows: CR % = (IC50 for
PMB/IC50 for analogs) × 100%.
Indirect Competitive CLEIA
The optimal concentrations of PMB-Gel and anti-PMB an-
tibody were selected using ELISA by checkerboard titra-
tion. The indirect competitive CLEIA was described as
follows: 100 μL/well of PMB-Gel in CBS (pH 9.6) was
coated on the 96-well polystyrene microtiter plates and
incubated at 4 °C overnight. On the following day, the
plate was washed three times using PBST and blocked by
adding 200 μL of PBS containing 2% BSA at 37 °C for
2 h. After a further washing step, 50 μL of diluted pAb and
50 μL of PMB standard solution were added to each well
and incubated at 37 °C for 40-min incubation. PMB stan-
dard solution was prepared by diluting with PBS at a series
of concentrations (5, 10, 25, 50, 100, 250, 500, 1000, and
2000 ng/mL). After three washes with PBST, 100 μL/well
of goat anti-mouse IgG-HRP was added and incubated at
37 °C for 40 min. Finally, 100 μL of substrate solution
prepared freshly was added into each well and incubated
for 5 min in the dark. Then, chemiluminescence intensity
was monitored on Synergy H1 (BioTek, VT, USA). The
standard curve was evaluated by plotting the chemilumi-
nescence intensity against the logarithm of each concentra-
tion and was fitted to a logistic equation using the Origin
8.0 program (OriginLab, Hampton, USA).
HPLC Analysis
The method was performed as the report described with
some modification (Chepyala et al. 2015; Wan et al.
2006). The liquid chromatographic system (Agilent
1260, USA) for PMB sulfate was equipped with an LC
pump delivering the mobile phase (VACN:VH2O = 90:10) at
a flow rate of 0.8 mL/min and with an automatic injector
with a loop of 60 μL. The stationary phase was packed in
a stainless steel column (100 × 4.6 mm, id 3.5 μm). The
column temperature was maintained at 25 °C. An integra-
tor was connected to the diode array detector (DAD) to
record the signals at 220 nm. A series of different con-
centrations of PMB were prepared in PBS. The calibration
curve was generated via linear regression, and the linear
range of PMB was calculated using the peak area ratio of
PMB to the external standard (PMB).
Spiked Sample Preparations and Analysis
To verify the developed methods, the chicken, pork, and
beef samples were purchased from the local market in
Yangling, Shaanxi Province, China. The samples were ex-
tracted in reference to a previous report (Yu et al. 2017);
briefly, each sample (1-g wet mass) was homogenized and
spiked with PMB standards at different concentrations
(100, 200, and 500 ng/g). Four milliliters of 0.1% formic
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acid and 2 mL of methanol were mixed with the tissue
sample. The mixture was sonicated for 30 min at 60 °C,
and the suspension was centrifuged (Eppendorf 5804R in-
strument, Eppendorf, Hamburg, Germany) at 4000g for
15 min at 4 °C. The supernatants were transferred to a
solid-phase extraction column and washed with 10 mL
H2O. The analyte was eluted from the column by 3 mL
methanol and then dried under nitrogen. At last, dried sam-
ples were re-dissolved in 1 mL PBS and tested using the
developed ELISA and CLEIA. The recovery rates were
calculated on the basis of the standard curve constructed
by ic-ELISA and ic-CLEIA.
Results
Characterization of the Antigen
Three absorbance curves (GBSA, PMB, and PMB-GBSA)
were observed after the UV screening from 190 to
400 nm. PMB did not have an absorption peak over
230 nm. PMB and GBSA showed a similar characteristic
absorption peak at 220 nm. For this reason, reducing
PAGE was performed to further confirm the conjugation
of PMB-GBSA (Fig. 2). PMB-GBSA showed larger mo-
lecular weight.
Optimization of PMB-Gel and Antiserum Work
Concentrations
The antibody working titer was determined by the
checkerboard method (Fig. 3). The OD450 value 1.0 in-
dicated that the best concentrations of the antiserum and
the coated PMB-Gel were fixed on 1:3000 and 1 μg/
mL, respectively.
Competitive ELISA
The sensitivity of ELISAwas determined under optimal con-
ditions. In the representative competitive inhibition curve for
PMB (Fig. 4), the regression curve equation of the anti-PMB
pAb was Y = − 0.340X + 1.322 (R2 = 0.984, n = 3), with the
IC50 value of 257.1 ng/mL and the limit of detection (IC10
value) of 17.4 ng/mL. The IC50 value demonstrated that the
antibody could be used for PMB detection with a linear range
from 25 to 2000 ng/mL.
Fig. 2 Reduced PAGE analysis on GBSA (lane 1) and PMB-GBSA
conjugate (lane 2)
Fig. 3 Checkerboard curve of antigen-antibody of PMB. Different sym-
bols represent increasing amount of the coated antigen
Fig. 4 Standard curve of the competitive ELISA for PMB
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Cross-reactivity and Sensitivity
The structural analogs and other antibiotics, including PME,
kanamycin, sulfadimethoxine, enrofloxacin, gentamicin, and
chloramphenicol, were used to evaluate the specificity of the
antibody obtained. The data showed that the pAb exhibited
high cross-reactivity for PME, where the cross-reactivity was
257.1% (Table 1). It was found that the pAb did not
recognize the other five commonly used in veterinary
antibiotics.
Development of Competitive CLEIA
The sensitivity of CLEIA was determined under the same
conditions as ELISA. The representative competitive inhibi-
tion curve (Fig. 5) revealed the regression curve equation of


















1416 Food Anal. Methods (2019) 12:1412–1419
Y = − 0.323X + 1.275 (R2 = 0.985, n = 3) with the IC50 value
of 250.8 ng/mL and the limit of detection (IC10) value of
14.5 ng/mL. The linear range was 25~2000 ng/mL.
PMB Sulfate Analysis in HPLC
A reversed-phase HPLC was developed for PMB determina-
tion by analyzing its major metabolite, PMB sulfate. The re-
tention time of PMB was 0.772 min. The regression curve
equation was Y = 4.572X − 63.683 (R2 = 0.996, n = 3). The
linearity ranged from 5.0 to 500.0 μg/mL. The LOQ, where
the signal-to-noise ratio equaled 10, was 5 μg/mL. The LOD,
where the signal-to-noise ratio equaled 3, was 2 μg/mL.
Precision and Recovery in the Sample Test
ELISA and CLEIA are broadly used as tools of qualitative
determination. To evaluate the accuracy and precision of the
developed test system in matrices, the spiked chicken, pork,
and beef samples containing different concentrations of PMB
(100, 200, and 500 ng/g, respectively) were detected using the
proposed ic-ELISA and ic-CLEIA, respectively, and both
methods showed high recoveries (Table 2) and low coeffi-
cients of variation (Table 2).
Discussion
PMB and PME are commonly used to control and treat animal
disease as well as promote fast and more efficient growth of
livestock. Improper use of them leads to the development of
antibiotic-resistant bacteria and puts animals and humans at risk
for the acquisition of antimicrobial drug–resistant pathogens.
PME residue determination in animal-derived food products
or animal feed is already reported. Still, there is little research
about PMB residue in these. A rapid and semi-quantitative
nanoparticle (AuNP)–based immunochromatographic test
(ICT) strip for PMB residues has been established (Li et al.
2018). Nevertheless, for quantitative detection of PMB, high
specificity of the anti-PMB antibody was generated from rab-
bits immunized with PMB-GBSA in this study. A high cross-
reactivity of the pAbwith PMEmay be attributable to their very
similar molecular structure. The difference between PMB and
PME is the sixth amino acid: PMB has a D-phenylalanine in its
Table 2 Recovery rates of PMB from fresh chicken, pork, and beef samples (n = 4)
Sample ELISA CLEIA
Spiked Measured Recovery RSD Measured Recovery RSD
(ng/g) (ng/g) (%) (%) (ng/g) (%) (%)
Chicken 0 < LOD – – < LOD – –
100 77.4 77.4 4.8 84.1 84.1 8.4
200 175.5 87.8 6.3 184.3 92.2 9.0
500 451.5 90.3 9.7 429.5 85.9 4. 0
Pork 0 < LOD – – < LOD – –
100 84.1 84.1 7.0 84.8 84.8 12.1
200 212.1 106.1 7.2 214.2 107.1 9.3
500 429.6 85.9 8.4 448.1 89.6 8.7
Beef 0 < LOD – – < LOD – –
100 81.5 81.5 7.3 88.8 88.8 7.0
200 189.6 94.8 4.6 202.5 101.3 5.0
500 519.9 104.0 7.7 427.3 85.5 9.2
RSD relative standard deviation
No HPLC results listed, because of its low sensitivity
Fig. 5 Standard curve of the competitive CLEIA for PMB
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cyclic portion, whereas in PME, there is a D-leucine in the same
position (Landman et al. 2008; Vaara 2010). The pAb could be
used for preliminary screening of PME and quantitative analy-
sis of PMB. During sample preparation, high protein content in
meat products occurs with PMB through hydrophobic interac-
tions and hydrogen bonds, which could interfere with the de-
termination of PMB using the developed assay. Hence, organic
solvent was picked to precipitate protein and extract PMB dur-
ing the pretreatment process of samples, which achieved good
extraction effect and reduced the matrix interference.
As an alternative to instrumental analytical methods,
ELISA and CLEIA have been considered as promising
choices for large sample screening in the detection of an-
tibiotic residues. As a fundamental and classical immuno-
assay, the ELISA has been applied widely with the advan-
tages of simplicity, specificity, and low cost. Nevertheless,
because the enhanced chemiluminescence reaction offers
the possibility of increasing the sensitivity of CLEIA com-
pared with conventional immunoassay detections, the
CLEIA has gained more attention in recent years (Lu
et al. 2011; Yu et al. 2014). Besides, the light intensity of
CLEIA can remain stable in 5 min after substrate addition,
thus providing rapid detection of the analytical signal. The
features of ic-ELISA and ic-CLEIA employed for the de-
tection of PMB have been compared. The ic-ELISA and ic-
CLEIA possess the same wide de tec t ion range
(25~2000 ng/mL). The sensibility of ic-ELISA is lower
than that of ic-CLEIA. Furthermore, the two developed
assays showed higher sensitivity than HPLC with DAD.
Conclusion
A polyclonal antibody against PMB was raised by immuniz-
ing New Zealand white rabbits with PMB-GBSA. The LOD
of ic-ELISA and ic-CLEIAwere 17.4 ng/mL and 14.5 ng/mL,
respectively. They were sensitive for quantitative analysis of
PMB and the large sample screening of PME inmeat samples.
The two methods demonstrated their potential as alternatives
to the commonly used chromatography methods.
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